• About Us
  • Contact Us
  • Today Headline
  • Write for us
Today Headline
No Result
View All Result
  • breaking news today
    • Politics news
    • Sports
    • Science News & Society
  • Entertainment News
    • Movie
    • Gaming
  • Technology News
    • Automotive
    • Software & IT
  • Health News
    • Lifestyle
    • Insurance
  • Finance News
    • Money
  • Enterprise
  • Contact Us
  • breaking news today
    • Politics news
    • Sports
    • Science News & Society
  • Entertainment News
    • Movie
    • Gaming
  • Technology News
    • Automotive
    • Software & IT
  • Health News
    • Lifestyle
    • Insurance
  • Finance News
    • Money
  • Enterprise
  • Contact Us
No Result
View All Result
TodayHeadline
No Result
View All Result

Medicare will cover Aduhelm only for those enrolled in clinical trials

April 8, 2022
in Health News
Reading Time: 2 mins read
medicare alzheimers drug 80203 – TodayHeadline



medicare alzheimers drug 80203 – TodayHeadline

CMS updated its stance on future Alzheimer’s drugs that also target the amyloid proteins thought to cause the disease. Should those drugs go through a traditional approval process, and not the accelerated approval process, patients would not need to be in a randomized, controlled trial.

Instead, they could be in a patient registry, which tracks how patients fare when they receive the drug. Unlike a randomized trial, it doesn’t require any patient to receive a placebo.

“We are really looking for real-world data to ensure that every patient has the same benefits,” said Tamara Syrek Jensen, the head of the coverage and analysis group within CMS’ Office of Clinical Standards and Quality.

The decision goes into effect immediately, meaning that patients who want to receive Aduhelm will need to go through a trial conducted through FDA. Biogen plans to begin screening patients for a post-marketing trial in May, which could meet CMS’ coverage standards.

Background: For the final determination, CMS reviewed more than 10,000 comments and 250 peer-reviewed studies.

At the time it was proposed, critics from the drug industry and patient advocacy groups — some of which receive a small percentage of their funding from pharmaceutical companies — had said that Medicare’s proposed narrow coverage of Aduhelm would effectively prevent most eligible patients from receiving the drug, which has an out-of-pocket cost of roughly $28,000 annually, because of the strict clinical trial requirements.

They have also cited the fact that CMS’ decision functionally overrides the FDA’s approval of the drug. Aduhelm, also known by the scientific name aducanumab, received accelerated approval last summer. The conditional approval requires Biogen to conduct a fourth, post-market randomized trial to prove that the drug benefits patients.

What’s next: Biogen is slated to begin screening patients for its mandated Phase IV trial for Aduhelm next month, in addition to the two ongoing trials it is running on the drug. One of these trials is observational, while the other is a continuation of a late-stage clinical trial.

  • Trending
  • Comments
  • Latest
GettyImages 1411799498 scaled – TodayHeadline

Seven easy April Fools’ pranks for kids to play on parents

super73 adventure series header – TodayHeadline

SUPER73 announces new electric bikes, fast charging motorcycle

1a3732be 81a5 4ee5 9239 b6821a0ee504 – TodayHeadline

YMTC set for chip comeback despite US export controls

ff590a10 d52e 427b bbab 2be5a91f5e24 – TodayHeadline

AI will not remedy all our real estate woes

f 150 lightning platinum – TodayHeadline

Ford F-150 Lightning Prices Increase Again

Report – Economics Bitcoin News – TodayHeadline

Report – Economics Bitcoin News

6428c85272b7290018d22c2c – TodayHeadline

Stormy Daniels Was Riding Horse Redemption When Trump’s Indictment Was Reported

HollywoodSIgn229388 H 2022 – TodayHeadline

CEO Bob Rosenthal Resigns From Formosa Group – The Hollywood Reporter

PopularStories

f 150 lightning platinum – TodayHeadline
Automotive

Ford F-150 Lightning Prices Increase Again

Report – Economics Bitcoin News – TodayHeadline
Money

Report – Economics Bitcoin News

6428c85272b7290018d22c2c – TodayHeadline
Finance News

Stormy Daniels Was Riding Horse Redemption When Trump’s Indictment Was Reported

HollywoodSIgn229388 H 2022 – TodayHeadline
Movie

CEO Bob Rosenthal Resigns From Formosa Group – The Hollywood Reporter

About Us

Todayheadline the independent news and topics discovery
A home-grown and independent news and topic aggregation . displays breaking news linking to news websites all around the world.

Follow Us

Latest News

f 150 lightning platinum – TodayHeadline

Ford F-150 Lightning Prices Increase Again

Report – Economics Bitcoin News – TodayHeadline

Report – Economics Bitcoin News

6428c85272b7290018d22c2c – TodayHeadline

Stormy Daniels Was Riding Horse Redemption When Trump’s Indictment Was Reported

f 150 lightning platinum – TodayHeadline

Ford F-150 Lightning Prices Increase Again

Report – Economics Bitcoin News – TodayHeadline

Report – Economics Bitcoin News

6428c85272b7290018d22c2c – TodayHeadline

Stormy Daniels Was Riding Horse Redemption When Trump’s Indictment Was Reported

  • Real Estate
  • Parenting
  • Cooking
  • NFL Games On TV Today
  • Travel and Tourism
  • Home & Garden
  • Pets
  • Privacy & Policy
  • Contact
  • About

© 2023 All rights are reserved Today headline

No Result
View All Result
  • Real Estate
  • Parenting
  • Cooking
  • NFL Games On TV Today
  • Travel and Tourism
  • Home & Garden
  • Pets
  • Privacy & Policy
  • Contact
  • About

© 2023 All rights are reserved Today headline

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.